After being named a "China's Most Promising Company" by Forbes in 2010, Runke has once again captured the attention of Forbes judges with its technological innovation, domestic leadership, position in high-end industries, and core competitiveness. This time, the company has been selected as one of the "China's Best Potential Companies" in 2012, with its ranking rising to 52nd place.
Since its inception, Runke has relied on technological innovation. Its R&D team successfully broke through the key technology of microalgae DHA production, making it a leading enterprise in China and one of the earliest in the world to possess this critical technology. The company is also a professional producer of ARA, with multiple technical indicators reaching industry-leading levels. Guided by market trends and relying on technological innovation, Runke consistently pursues high stability and high purity as its quality objectives. Its primary research focus is on the development of DHA and ARA products and their applications and expansions in the dairy, grain and oil, food, and healthcare industries.
Forbes has continuously sought outstanding companies in the business sector, gradually establishing its unique style and growing into a prestigious international mainstream financial media group. As China's position in the global economy becomes increasingly important, Forbes' attention to China has also intensified. Forbes brings its mission and positioning to China, with the Chinese edition adhering to the mother magazine's long-standing commitment to entrepreneurial spirit. It serves as a tool for creating wealth for senior corporate decision-makers in China who pursue entrepreneurial values and the spirit of free enterprise. Forbes is best known for its Forbes Billionaires List, which is widely followed. Other Forbes rankings, such as the World's Billionaires List, Forbes China 400 Rich List, Forbes China Top 100 Most Promising Companies, and Global Chinese Rich List, also generate significant buzz.
Runke's corporate vision is to become an internationally renowned and domestically leading modern biotechnology enterprise. Congratulations to the company on this well-deserved recognition from Forbes. Let's keep up the good work!
